Clinical Edge Journal Scan

Clinical Edge Journal Scan

DPP4 inhibitor ups risk for cholecystitis in T2D

Publish date: July 31, 2022

• Read More

Clinical Edge Journal Scan

SGLT2i vs GLP-1RA or DPP4i lowers the risk for new-onset AF in T2D

Publish date: July 31, 2022

• Read More

Clinical Edge Journal Scan

Semaglutide improves glycemic control in patients with prediabetes

Publish date: July 31, 2022

• Read More

Clinical Edge Journal Scan

T2D: Significant improvement in glycemic control with efpeglenatide

Publish date: July 31, 2022

• Read More

Clinical Edge Journal Scan

Commentary: Benefits of GLP-1 Receptor Agonists and Studies of Continuous Glucose Monitoring, July 2022

Publish date: July 1, 2022

• Read More

Clinical Edge Journal Scan

Glycemic variability remains a concern even in T2D patients with well-controlled glucose status

Publish date: June 22, 2022

• Read More

Clinical Edge Journal Scan

MLR may have clinical and predictive significance in patients with T2D and PDR

Publish date: June 22, 2022

• Read More

Clinical Edge Journal Scan

Glycemic variability remains a concern even in T2D patients with well-controlled glucose status

Publish date: June 22, 2022

• Read More

Clinical Edge Journal Scan

T2D: Noninferior efficacy with adding low-dose vs. standard-dose lobeglitazone to metformin and DPP4i

Publish date: June 22, 2022

• Read More

Clinical Edge Journal Scan

Obesity may be protective against diabetic retinopathy in T2D

Publish date: June 22, 2022

• Read More

Pages

• « first
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• last »